Clinical and Laboratory Correlates of Pneumocystis carinii Pneumonia in Children Infected With HIV

Edward Connor, Mark Bagarazzi, George Mcsherry, Bart Holland, Mary Boland, Thomas Denny, James Oleske

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

The case histories of 27 children with Pneumocystis carinii pneumonia (PCP) who were followed up in the AIDS Program at the Children’s Hospital of New Jersey, Newark, are reviewed. The mean and median age at PCP diagnosis were 10.8 and 7.7 months, respectively. All of the children had other clinical evidence of infection with the human immunodeficiency virus that was documented prior to the diagnosis of PCP or found at the time of PCP diagnosis. Most patients who presented to the hospital were acutely ill, and complications of treatment occurred in 70%. Overall, 89% of the patients died and 70% survived for less than 6 months after diagnosis of PCP. Median survival after the diagnosis of PCP was only 2.0 months and the median life span of children with PCP was only 14.4 months. Only 40% of children with PCP had CD4 lymphocyte counts at or below the threshold for institution of PCP prophylaxis in adults of 200 × 106 cells/L (200 cells/mm3).

Original languageEnglish (US)
Pages (from-to)1693-1697
Number of pages5
JournalJAMA: The Journal of the American Medical Association
Volume265
Issue number13
DOIs
StatePublished - Apr 3 1991

Fingerprint

Pneumocystis Pneumonia
HIV
CD4 Lymphocyte Count
Acquired Immunodeficiency Syndrome
Survival

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Connor, Edward ; Bagarazzi, Mark ; Mcsherry, George ; Holland, Bart ; Boland, Mary ; Denny, Thomas ; Oleske, James. / Clinical and Laboratory Correlates of Pneumocystis carinii Pneumonia in Children Infected With HIV. In: JAMA: The Journal of the American Medical Association. 1991 ; Vol. 265, No. 13. pp. 1693-1697.
@article{18bba150396c4a1d8f1361eb00ecf900,
title = "Clinical and Laboratory Correlates of Pneumocystis carinii Pneumonia in Children Infected With HIV",
abstract = "The case histories of 27 children with Pneumocystis carinii pneumonia (PCP) who were followed up in the AIDS Program at the Children’s Hospital of New Jersey, Newark, are reviewed. The mean and median age at PCP diagnosis were 10.8 and 7.7 months, respectively. All of the children had other clinical evidence of infection with the human immunodeficiency virus that was documented prior to the diagnosis of PCP or found at the time of PCP diagnosis. Most patients who presented to the hospital were acutely ill, and complications of treatment occurred in 70{\%}. Overall, 89{\%} of the patients died and 70{\%} survived for less than 6 months after diagnosis of PCP. Median survival after the diagnosis of PCP was only 2.0 months and the median life span of children with PCP was only 14.4 months. Only 40{\%} of children with PCP had CD4 lymphocyte counts at or below the threshold for institution of PCP prophylaxis in adults of 200 × 106 cells/L (200 cells/mm3).",
author = "Edward Connor and Mark Bagarazzi and George Mcsherry and Bart Holland and Mary Boland and Thomas Denny and James Oleske",
year = "1991",
month = "4",
day = "3",
doi = "10.1001/jama.1991.03460130085027",
language = "English (US)",
volume = "265",
pages = "1693--1697",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "13",

}

Clinical and Laboratory Correlates of Pneumocystis carinii Pneumonia in Children Infected With HIV. / Connor, Edward; Bagarazzi, Mark; Mcsherry, George; Holland, Bart; Boland, Mary; Denny, Thomas; Oleske, James.

In: JAMA: The Journal of the American Medical Association, Vol. 265, No. 13, 03.04.1991, p. 1693-1697.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical and Laboratory Correlates of Pneumocystis carinii Pneumonia in Children Infected With HIV

AU - Connor, Edward

AU - Bagarazzi, Mark

AU - Mcsherry, George

AU - Holland, Bart

AU - Boland, Mary

AU - Denny, Thomas

AU - Oleske, James

PY - 1991/4/3

Y1 - 1991/4/3

N2 - The case histories of 27 children with Pneumocystis carinii pneumonia (PCP) who were followed up in the AIDS Program at the Children’s Hospital of New Jersey, Newark, are reviewed. The mean and median age at PCP diagnosis were 10.8 and 7.7 months, respectively. All of the children had other clinical evidence of infection with the human immunodeficiency virus that was documented prior to the diagnosis of PCP or found at the time of PCP diagnosis. Most patients who presented to the hospital were acutely ill, and complications of treatment occurred in 70%. Overall, 89% of the patients died and 70% survived for less than 6 months after diagnosis of PCP. Median survival after the diagnosis of PCP was only 2.0 months and the median life span of children with PCP was only 14.4 months. Only 40% of children with PCP had CD4 lymphocyte counts at or below the threshold for institution of PCP prophylaxis in adults of 200 × 106 cells/L (200 cells/mm3).

AB - The case histories of 27 children with Pneumocystis carinii pneumonia (PCP) who were followed up in the AIDS Program at the Children’s Hospital of New Jersey, Newark, are reviewed. The mean and median age at PCP diagnosis were 10.8 and 7.7 months, respectively. All of the children had other clinical evidence of infection with the human immunodeficiency virus that was documented prior to the diagnosis of PCP or found at the time of PCP diagnosis. Most patients who presented to the hospital were acutely ill, and complications of treatment occurred in 70%. Overall, 89% of the patients died and 70% survived for less than 6 months after diagnosis of PCP. Median survival after the diagnosis of PCP was only 2.0 months and the median life span of children with PCP was only 14.4 months. Only 40% of children with PCP had CD4 lymphocyte counts at or below the threshold for institution of PCP prophylaxis in adults of 200 × 106 cells/L (200 cells/mm3).

UR - http://www.scopus.com/inward/record.url?scp=0025854525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025854525&partnerID=8YFLogxK

U2 - 10.1001/jama.1991.03460130085027

DO - 10.1001/jama.1991.03460130085027

M3 - Article

C2 - 1672168

AN - SCOPUS:0025854525

VL - 265

SP - 1693

EP - 1697

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 13

ER -